-
- South Korea / 2012
Crosslinked HA Filler: Diosha
- ◾ Price: Negotiable
- ◾ MOQ: Negotiable
Crosslinked HA Filler: Diosha
- ◾ Price: Negotiable
- ◾ MOQ: Negotiable
-
Required Quantity
-
Brand name
-
Shipping / Lead TimeNegotiable / Negotiable
-
Keyword
-
Category
Specifications
| Size | - | Weight | - | Stock | - |
|---|---|---|---|---|---|
| Country of Origin | South Korea | ||||
| Production method | Negotiable | ||||
Trade Terms
| Payment Terms | T/T, Western Union | ||||
|---|---|---|---|---|---|
| Price(FOB) | Negotiable | MOQ | Negotiable | ||
| Transportation | - | ||||
| Lead time | Negotiable | Shipping time | Negotiable | ||
Company
-
Country / Year Established
-
Membership
- VIP
Business typeManufacturer
-
Verified Certificate
-
6
-
-
6
-
Main Export Markets
-
Colombia
-
Hungary
-
Italy
-
Saudi Arabia
-
Switzerland
-
Product Description
BRAND STORY
① Feature
- Non-animal hyaluronic acid, Non-Immunogenic.
- Low BDDE concentration safe/ crosslinked HA
- Biocompatibility.
- Soft/ Medium/ Hard.
- 1ml x 1/ box
② Indications
- Tear Trough, Cheek, Marionette Line, Lips, Forehead, Finelines, Nose, Nasolabial, Chin, etc.
Injection into the upper dermis(DIOSHA Soft) or the dermis(DIOSHA Medium), or the deep dermis to superficial subcutis(DIOSHA Hard)
Medical Device KFDA
approval Graft/Prosthesis, Biomaterial
Proven safety and efficacy
Through multicenter clinical trial, Safety and efficacy of DIOSHA have been proven
Non-animal Hyaluronic acid
Usage of HA produced by bacterial fermentation (Streptococcus equi)
Biocompatibility, Non-Toxin, Non-Immunogenic
Gel Type
- HA Conc.: 20mg/ml (2%)
- High Viscosity Gel: 2,700,000 Cp
- Injection Force: 10N
BDDE Crosslinked HA
- BDDE cross-linked HA
- To overcome the short biodegradability of natural HA
- Improvement of the sustainability
- Monophasic gel (Duration: 6-12 months)
| Composition | Cross-Linked Hyaluronic acid (20mg/ml) |
| Particle size | 150 ~ 250μm |
| Application Site | Fine wrinkles and detailed shaping |
| Injection Area | Upper dermis |
| Syringe | 1.0ml |
| Duration | 8-12 Months |
| Expiration | 24 months |
| Storage Temp | 2-25°C |
| Packing | 1 Syringe/30GX2 needles |
| Lidocaine | X |
| Composition | Cross-Linked Hyaluronic acid (20mg/ml) |
| Particle size | 350 ~ 600μm |
| Application Site | Moderate to severe wrinkles and folds |
| Injection Area | Lower dermis, Upper Sub-Q |
| Syringe | 1.Oml |
| Duration | 12-18 Months |
| Expiration | 24 months |
| Storage Temp | 2--25°C |
| Packing | 1 Syringe/27Gx2 needles |
| Lidocaine | X |
| Composition | Cross-Linked Hyaluronic acid (20mg/ml) |
| Particle size | 800 ~ 1,100μm |
| Application Site | Severe wrinkles and greater volume |
| Injection Area | Low Sub-Q |
| Syringe | 1.Oml |
| Duration | 12-18 Months |
| Expiration | 24 months |
| Storage Temp | 2--25°C |
| Packing | 1 Syringe/25GX2 needles |
| Lidocaine | X |
_thread_(Cog,_Mold,_Screw,_multi)_2.jpg "CE approved PLCL / P(LA/CL) thread (Cog, Mold, Screw, multi)")
